Phase 2b Randomized Study of Nemolizumab in Adults with Moderate-Severe Atopic Dermatitis and Severe Pruritus

This study evaluated nemolizumab plus topical corticosteroids in patients with AD and severe pruritus and found a significant effect on cutaneous signs of AD (by EASI and IGA), plus a rapid reduction of pruritus.

Source: Journal of Allergy and Clinical Immunology - August 22, 2019 Category: Allergy & Immunology Authors: Jonathan I. Silverberg, Andreas Pinter, Grazyna Pulka, Yves Poulin, Jean-David Bouaziz, Andreas Wollenberg, D édée F. Murrell, Andrew Alexis, Lisa Lindsey, Faiz Ahmad, Christophe Piketty, Alan Clucas Source Type: research